Navigation Links
Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
Date:5/18/2011

l, two formulations of PT003 were studied, each containing 9.6 mcg FF plus one of two doses of GP: 36 mcg or 72 mcg. In addition, to investigate the effective dose range of FF MDI, a 7.2 mcg BID dose was also tested.  

One hundred eighteen patients were randomized in the Phase 2b study to receive four of the  following eight treatments  in a cross-over study: 36 mcg GP/9.6 mcg FF (PT003), 72 mcg GP/9.6 mcg FF (PT003), 36 mcg GP (PT001), 7.2 mcg FF (PT005) , 9.6 mcg FF (PT005), Spiriva, Foradil and placebo. Placebo, PT003, PT001 and PT005 were administered BID via HFA MDI for one week while Spiriva and Foradil were administered according to their approved label: 18 mcg once daily (via Handihaler® inhaler) and 12 mcg BID (via Aerolizer® inhaler), respectively, each for one week.

About COPD

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable lung disease that is the fourth leading cause of death in the United States. Each year 12 million Americans are diagnosed with COPD and an additional 12 million Americans may have COPD but remain undiagnosed. Research shows that many do not get optimal treatment.

Bronchodilator medications are central to symptom management and are prescribed on an as-needed or regular basis to prevent or reduce symptoms. Long-acting inhaled bronchodilators have been shown to be most effective and convenient. Combining bronchodilators of different pharmacological classes, as recommended by The Global Initiative for Chronic Obstructive Lung Diseases (GOLD), has been shown to improve efficacy and may decrease the risk of side effects compared to increasing the dose of a single bronchodilator. As the course of COPD progresses, regular treatment with inhaled glucocorticosteroids may be added to bronchodilator treatment.
'/>"/>

SOURCE Pearl Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
2. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
3. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
4. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
5. Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
6. Regency Therapeutics and Daiichi Sankyo Announce Launch and Commercial Availability of SPRIX® (ketorolac tromethamine) Nasal Spray
7. Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
8. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
9. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
10. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
11. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/3h534b/infectious ... Disease Diagnostics Market by Product, Application, Technology, End User ... offering. , The infectious disease diagnostics market ... reach $18,156.2 million by 2019 from $12,422.8 million in ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has announced the ... Product & by End User - Global Forecast to 2019" ... allergy diagnostics market is valued at $1,228.58 million in 2014 ... to reach $2,230.72 million by 2019. Allergy diagnostics is used ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/tl6pqb/xray_detectors ) ... by Detector Type, Applications & by FPD Panel Size - ... , The X-ray detectors market is a growing ... its inception, such as a shift from film to filmless ...
Breaking Medicine Technology:Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3Global X-Ray Detectors (Flat Panel, Computed Radiography, CCD, Line-Scan) Market - Forecast to 2019 2Global X-Ray Detectors (Flat Panel, Computed Radiography, CCD, Line-Scan) Market - Forecast to 2019 3
... , STAMFORD, Conn., Nov. 13 ... it will be releasing a free trial version of its ... Sessions conference, taking place this November 15-17 in Orlando. Zargis ... of the companion hardware -- the 3M Littmann Electronic Stethoscope ...
... , , SILVER SPRING, Md., ... today approved Lysteda tablets (tranexamic acid), the first non-hormonal ... works by stabilizing a protein that helps blood to ... ) , Heavy menstrual bleeding is reported each year ...
Cached Medicine Technology:Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 3FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 2
(Date:1/22/2015)... January 23, 2015 The U.S. Pharmacopeial ... DICVP, Director of Clinical Pharmacy Services at North Carolina ... recipient of the 2015 Beal Award for Distinguished Volunteer ... has relied on the contributions of volunteer experts to ...
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ has ... (PPHA). The PPHA's passion for others' well-being and shared ... treated for obstructive sleep apnea (OSA) has propelled them into ... the valley. The most recent plans for an event will ...
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... Now! Coalition applauds the House,s important decision to allocate ... American Recovery and Reinvestment Act for incentives to promote ... this outcome," Joel White, executive director of the Coalition ... coalition has advocated for legislation with significant funding provisions ...
... Jan. 29, 2009 Mice whose fat cells were allowed to ... when fed a high-fat diet, researchers at UT Southwestern Medical Center ... mice lacked a protein called collagen VI, which normally surrounds fat ... around a water balloon. The findings appear online and in a ...
... that exercise may be a factor in recovering from ... and knee osteoarthritis (OA). One study involving a progressive ... it enhanced clinical improvement almost to the level of ... examine the relationship between four components of physical activity ...
... (OA) causes disability and is a major public health ... 4 and 6 sulfate (CS) on OA progression and ... dietary supplements in the U.S., has been approved as ... many European countries. The study was published in the ...
... North State Bancorp (OTC,Bulletin Board: NSBC) (the "Company"), the ... $687.6 million as of December 31, 2008,compared to total ... increase,of $140.1 million or 25.6%. , ... 31, 2008 were $612.7,million and total loans were $546.4 ...
... smoking laws make it this year,s worst city for asthmatics, ... Louis is now the 2009 "Asthma Capital of the United ... annual ranking of the 100 most challenging places to live ... 2008, St. Louis went to the top of this year,s ...
Cached Medicine News:Health News:UT Southwestern researchers identify protein that may explain 'healthy' obesity 2Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 2Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 3Health News:Chondroitin slows progression and relieves symptoms of knee osteoarthritis 2Health News:North State Bancorp Reports Profitable 2008 2Health News:North State Bancorp Reports Profitable 2008 3Health News:North State Bancorp Reports Profitable 2008 4Health News:North State Bancorp Reports Profitable 2008 5Health News:North State Bancorp Reports Profitable 2008 6Health News:St. Louis Ranked America's 'Asthma Capital' 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: